Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Experiences of Oral Corticosteroid Use and Adverse Effects: A National Cross-Sectional Survey of People with Asthma.
Patient Prefer Adherence
January 2025
Respiratory Research@Alfred, Monash University, Melbourne, VIC, Australia.
Purpose: Oral corticosteroids (OCS) are an effective treatment for severe uncontrolled asthma or asthma exacerbations, but frequent bursts or long-term use carry serious and sometimes irreversible adverse effects, or complications such as adrenal insufficiency upon discontinuation. Our aim was to survey people with asthma on their experiences of, and attitudes towards, using OCS.
Patients And Methods: This study was a national descriptive cross-sectional survey of people with asthma in Australia.
ECMO: more than just a bridge over troubled waters?
Lancet Respir Med
October 2024
Adult Intensive Care Services, The Prince Charles Hospital, Brisbane, QLD, Australia; Faculty of Health Sciences & Medicine, Bond University, Gold Coast, QLD, Australia; Faculty of Health, Queensland University of Technology, Brisbane, QLD, Australia; Faculty of Medicine, University of Queensland, Brisbane, QLD, Australia.
Investigating non-inferiority of internet-delivered versus face-to-face cognitive behavioural therapy for insomnia (CBT-I): a randomised controlled trial (iSleep well).
Trials
June 2024
Department of Health Psychology and Applied Biological Psychology, Institute of Sustainability Psychology, Leuphana University of Lüneburg, Lüneburg, Germany.
Background: Insomnia is a highly prevalent disorder associated with numerous adverse health outcomes. Cognitive behavioural therapy for insomnia (CBT-I) is recommended as first-line treatment by clinical guidelines but is accessible to only a minority of patients suffering from insomnia. Internet-delivered CBT-I (iCBT-I) could contribute to the widespread dissemination of this first-line treatment.
View Article and Find Full Text PDFArticle Synopsis
- The GBD 2021 study aims to quantify the health impacts of 88 risk factors across 204 countries from 1990 to 2021, helping to inform public health policies.
- The analysis utilized over 54,000 data sources to assess 631 risk-outcome pairs, determining how specific risk factors contribute to various health issues.
- By calculating relative risks and population attributable fractions, the study provides insights into the disease burden tied to each risk factor, measured in disability-adjusted life-years (DALYs).
Problematic substance use in depressed adolescents: Prevalence and clinical correlates.
Addict Behav Rep
June 2024
Center for Depression Research and Clinical Care, Peter O'Donnell Jr. Brain Institute and Department of Psychiatry, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390, USA.
Background: Substance use among adolescents is common and associated with significant consequences, including depression. Adolescents can experience myriad problems related to early onset substance use and depression, making further understanding of this comorbidity necessary.
Method: Participants were a subset from a large-scale performance improvement project and consisted of adolescents aged 12-18 who screened positive for depression during their routine medical or psychiatric appointment and who then completed the substance use assessment Car, Relax, Alone, Forget, Friends, Trouble Version 2.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!